HIGH ABSORPTION CALCIUM II
Natural health product licensed in Canada
- Licence holder
- Tianshi Health Products Inc.
- NPN or DIN-HM
- 80018893
- Status
- Active licence
- Licence date
- 20 May 2010
- Revision date
- Not provided
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Magnésium Source : Magnesium oxide from aquamin seaweed | 50 mg | Not calculated |
| Calcium Source : Calcium carbonate from aquamin seaweed | 500 mg | Not calculated |
| Vitamine C Source : Acide ascorbique | 10 mg | Not calculated |
| Vitamine D Source : Cholécalciférol Potency : 200 UI | 5 mcg | Not calculated |
| Vitamine A Source : Palmitate de rétinyle tout trans Potency : 900 UI | 270 mcg EAR | Not calculated |
Non-medicinal ingredients
Saveur de vanille naturelle, Canola oil powder, Maltodextrine, poudre de lait écrémé
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 10 g | Not specified |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps in the development and maintenance of bones and teeth, especially in childhood, adolescence and young adulthood. Calcium intake, when combined with sufficient vitamin D, a healthy diet, and regular exercise, may reduce the risk of developing osteoporosis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80018893
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.